CAMBRIDGE, Mass., Feb. 22, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, announced today that the company will participate in the Citi 2012 Global Healthcare Conference in New York City. Marc Beer, Chief Executive Officer of Aegerion, is scheduled to present on Monday, February 27, 2012 at 3:30 p.m. ET.
